Bausch Health Companies Inc. - stock earnings
BHC Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | 1.15 / 0.75 | - | - / 2.2 billion | - |
BHC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 395.0 million USD | 2.4 billion USD |
| 2023Q3 | -378.0 million USD | 2.2 billion USD |
| 2023Q2 | 26.0 million USD | 2.2 billion USD |
| 2023Q1 | -209.0 million USD | 1.9 billion USD |
| 2022Q4 | -410.0 million USD | 2.2 billion USD |
| 2022Q3 | 399.0 million USD | 2.0 billion USD |
| 2022Q2 | -139.0 million USD | 2.0 billion USD |
| 2022Q1 | -66.0 million USD | 1.9 billion USD |
| 2021Q4 | 69.0 million USD | 2.2 billion USD |
| 2021Q3 | 188.0 million USD | 2.1 billion USD |
| 2021Q2 | -595.0 million USD | 2.1 billion USD |
| 2021Q1 | -610.0 million USD | 2.0 billion USD |
| 2020Q4 | -153.0 million USD | 2.2 billion USD |
| 2020Q3 | 71.0 million USD | 2.1 billion USD |
| 2020Q2 | -326.0 million USD | 1.7 billion USD |
| 2020Q1 | -152.0 million USD | 2.0 billion USD |
| 2019Q4 | -1.5 billion USD | 2.2 billion USD |
| 2019Q3 | -49.0 million USD | 2.2 billion USD |
| 2019Q2 | -171.0 million USD | 2.2 billion USD |
| 2019Q1 | -52.0 million USD | 2.0 billion USD |
| 2018Q4 | -344.0 million USD | 2.1 billion USD |
| 2018Q3 | -350.0 million USD | 2.1 billion USD |
| 2018Q2 | -873.0 million USD | 2.1 billion USD |
| 2018Q1 | -2.7 billion USD | 2.0 billion USD |
| 2017Q4 | 513.0 million USD | 2.2 billion USD |
| 2017Q3 | 1.3 billion USD | 2.2 billion USD |
| 2017Q2 | -38.0 million USD | 2.2 billion USD |
| 2017Q1 | 628.0 million USD | 2.1 billion USD |
| 2016Q4 | -515.0 million USD | 2.4 billion USD |
| 2016Q3 | -1.2 billion USD | 2.5 billion USD |
| 2016Q2 | -302.3 million USD | 2.4 billion USD |
| 2016Q1 | -336.4 million USD | 2.8 billion USD |
| 2015Q4 | -361.9 million USD | 2.7 billion USD |
| 2015Q3 | 49.5 million USD | 2.8 billion USD |
| 2015Q2 | -53.0 million USD | 2.7 billion USD |
| 2015Q1 | 73.7 million USD | 2.2 billion USD |
| 2014Q4 | 534.9 million USD | 2.3 billion USD |
| 2014Q3 | 275.4 million USD | 2.1 billion USD |
| 2014Q2 | 125.8 million USD | 2.0 billion USD |
| 2014Q1 | -22.6 million USD | 1.9 billion USD |
| 2013Q4 | 123.8 million USD | 2.1 billion USD |
| 2013Q3 | -973.2 million USD | 1.5 billion USD |
| 2013Q2 | 10.9 million USD | 1.1 billion USD |
| 2013Q1 | -27.5 million USD | 1.1 billion USD |
| 2012Q4 | -89.1 million USD | 986.3 million USD |
| 2012Q3 | 7.6 million USD | 884.1 million USD |
| 2012Q2 | -21.6 million USD | 820.1 million USD |
| 2012Q1 | -12.9 million USD | 856.1 million USD |
| 2011Q4 | 55.9 million USD | 688.5 million USD |
| 2011Q3 | 40.9 million USD | 600.6 million USD |
| 2011Q2 | 56.4 million USD | 609.4 million USD |
| 2011Q1 | 6.5 million USD | 565.0 million USD |
| 2010Q4 | -31.1 million USD | 514.6 million USD |
| 2010Q3 | -207.9 million USD | 208.3 million USD |
| 2010Q2 | 34.0 million USD | 238.8 million USD |
| 2010Q1 | -3.2 million USD | 219.6 million USD |
| 2009Q4 | 73.0 million USD | 241.1 million USD |
| 2009Q3 | 40.4 million USD | 212.5 million USD |
| 2009Q2 | 24.1 million USD | 193.5 million USD |
| 2009Q1 | 39.0 million USD | 173.3 million USD |
| 2008Q4 | 120.4 million USD | 181.5 million USD |
| 2008Q3 | 48.4 million USD | 181.1 million USD |
| 2008Q2 | -25.3 million USD | 186.1 million USD |
| 2008Q1 | 56.4 million USD | 208.5 million USD |
| 2007Q4 | -32.0 million USD | 203.9 million USD |
| 2007Q3 | 65.9 million USD | 188.9 million USD |
| 2007Q2 | 67.8 million USD | 203.0 million USD |
| 2007Q1 | 93.8 million USD | 242.8 million USD |
| 2006Q4 | 115.3 million USD | 307.6 million USD |
| 2006Q3 | -56.5 million USD | 289.6 million USD |
| 2006Q2 | 80.6 million USD | 252.8 million USD |
| 2006Q1 | -27.5 million USD | 287.6 million USD |
| 2005Q4 | -27.5 million USD | 287.6 million USD |
| 2005Q3 | 101.7 million USD | 258.1 million USD |
| 2005Q2 | 3.7 million USD | 217.4 million USD |
| 2005Q1 | -62.2 million USD | 277.9 million USD |
| 2004Q4 | -62.2 million USD | 277.9 million USD |
| 2004Q3 | 49.6 million USD | 215.7 million USD |
| 2004Q2 | 44.2 million USD | 206.3 million USD |
| 2004Q1 | -102.2 million USD | 199.7 million USD |
| 2003Q4 | -102.2 million USD | 199.7 million USD |
| 2003Q3 | 13.0 million USD | 215.3 million USD |
| 2003Q2 | -1.0 million USD | 217.3 million USD |
| 2003Q1 | -102.8 million USD | 238.7 million USD |
| 2002Q4 | -102.8 million USD | 238.7 million USD |
| 2002Q3 | 75.0 million USD | 208.9 million USD |
| 2002Q2 | 62.6 million USD | 185.1 million USD |
| 2002Q1 | -18.9 million USD | 178.3 million USD |
| 2001Q4 | -18.9 million USD | 178.3 million USD |
| 2001Q3 | 33.1 million USD | 152.2 million USD |
| 2001Q2 | 44.1 million USD | 133.5 million USD |
| 2001Q1 | -60.8 million USD | 113.2 million USD |
| 2000Q4 | -60.8 million USD | 113.2 million USD |
| 2000Q3 | -102.6 million USD | 88.7 million USD |
| 2000Q2 | 22.3 million USD | 60.4 million USD |
| 2000Q1 | -6.9 million USD | 46.9 million USD |
| 1999Q4 | 25.0 million USD | 66.5 million USD |
| 1999Q3 | 17.1 million USD | 45.6 million USD |
| 1999Q2 | 12.1 million USD | 36.2 million USD |
| 1999Q1 | 14.8 million USD | 36.7 million USD |
| 1998Q4 | 14.8 million USD | 36.7 million USD |
| 1998Q3 | 13.2 million USD | 29.0 million USD |
| 1998Q2 | 9.5 million USD | 25.3 million USD |
| 1998Q1 | 7.8 million USD | 21.9 million USD |
| 1997Q4 | 13.2 million USD | 26.3 million USD |
| 1997Q3 | 9.4 million USD | 21.2 million USD |
| 1997Q2 | 7.1 million USD | 18.5 million USD |
| 1997Q1 | 5.9 million USD | 13.9 million USD |
| 1996Q4 | 5.9 million USD | 13.9 million USD |
| 1996Q3 | 6.3 million USD | 17.8 million USD |
| 1996Q2 | 3.2 million USD | 9.2 million USD |
| 1996Q1 | 4.7 million USD | 16.9 million USD |
| 1995Q4 | 3.2 million USD | 9.2 million USD |
| 1995Q3 | 1.0 million USD | 3.0 million USD |
| 1995Q2 | 400000 USD | 2.6 million USD |
| 1995Q1 | 1.2 million USD | 5.5 million USD |
| 1994Q4 | 400000 USD | 5.1 million USD |
| 1994Q3 | 400000 USD | 5.3 million USD |
| 1994Q2 | -2.0 million USD | 1.3 million USD |
| 1994Q1 | 2.5 million USD | 2.5 million USD |
BHC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -592.0 million USD | 8.8 billion USD |
| 2022 | -212.0 million USD | 8.1 billion USD |
| 2021 | -937.0 million USD | 8.4 billion USD |
| 2020 | -559.0 million USD | 8.0 billion USD |
| 2019 | -1.8 billion USD | 8.6 billion USD |
| 2018 | -4.1 billion USD | 8.4 billion USD |
| 2017 | 2.4 billion USD | 8.7 billion USD |
| 2016 | -2.4 billion USD | 9.7 billion USD |
| 2015 | -266.2 million USD | 10.5 billion USD |
| 2014 | 913.5 million USD | 8.3 billion USD |
| 2013 | -866.1 million USD | 5.8 billion USD |
| 2012 | -116.0 million USD | 3.5 billion USD |
| 2011 | 159.6 million USD | 2.5 billion USD |
| 2010 | -208.2 million USD | 1.2 billion USD |
| 2009 | 176.5 million USD | 820.4 million USD |
| 2008 | 199.9 million USD | 757.2 million USD |
| 2007 | 195.5 million USD | 842.8 million USD |
| 2006 | 203.9 million USD | 1.1 billion USD |
| 2005 | 89.0 million USD | 935.5 million USD |
| 2004 | 52.7 million USD | 886.5 million USD |
| 2003 | -27.3 million USD | 823.7 million USD |
| 2002 | 87.8 million USD | 788.0 million USD |
| 2001 | 87.4 million USD | 583.3 million USD |
| 2000 | -148.0 million USD | 309.2 million USD |
| 1999 | 62.5 million USD | 176.5 million USD |
| 1998 | 45.4 million USD | 112.8 million USD |
| 1997 | 35.2 million USD | 82.4 million USD |
| 1996 | 5.9 million USD | 20.6 million USD |
| 1995 | 5.9 million USD | 20.6 million USD |
| 1994 | 9.5 million USD | 17.3 million USD |
| 1993 | 3.9 million USD | 11.1 million USD |
BHC
Price: $7.82
52 week price:
Earnings Per Share: -1.62 USD
P/E Ratio: -3.07
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 1.8 million
Market Capitalization: 3.8 billion
Average Dividend Frequency: 4